About Mentari Therapeutics
Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention.
The company’s products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways.
The company was incorporated in 2025 and is based in Sacramento, California.
